U.S. Preventive Medicine Acquires Specialty Disease ...(e: patient and physician education;indiv...),Health

Date:10/2/2007

e: patient and physician education; individualized care plans; clinical data gathering and analysis; and outcomes reporting. The company has been awarded numerous contracts throughout the nation and has branded several technology products to improve effectiveness and provide a competitive distinction in a quickly growing industry.

"Specialty Disease Management has proven that it can reduce health expenditures and improve clinical outcomes for people with chronic diseases -- our intent is to cover the full spectrum of care management," said Fred Goldstein, Founder, President and CEO of Specialty Disease Management. "With the national brand presence of U.S. Preventive Medicine, we can expand the scope and value of our services to a larger percent of the U.S. and international populations.

Specialty Disease Management Services contracts with employers, health plans, self insured organizations, third party administration organizations, integrated delivery organizations, physician practices and others to provide services for complex diseases that include asthma, diabetes, coronary artery disease, chronic obstructive pulmonary disease, HIV/AIDS, hypertension, heart failure, obesity, depression and schizophrenia.

By providing practical solutions at every point in the healthcare continuum of an individual's life, U.S. Preventive Medicine will have a complete toolkit to offer employers, government agencies and consumers -- regardless of where they reside. The company licenses its proprietary methodology, technology and branding assets to a health provider, which operates a local point-of-care -- The Center for Preventive Medicine(R) -- in a geographic territory on an exclusive basis. Individually, The Center for Preventive Medicine delivers a consistent suite of prevention services; collectively, Centers across the country form the U.S. Prevention Network(TM). The company also is launching The Prevention Plan(R), a groundbreaking defined health benefit for
'/>"/>

SOURCE U.S. Preventive Medicine Copyright©2007 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4
Related medicine technology :

1. Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
2. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
3. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
6. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
7. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
8. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
9. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
10. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
11. Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD